Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Global today 11:44
"We'll be heading towards £1.20 soon if everyday is a 5% drop day". Actually if it drops 5% everyday it will eventually end up as 10p. So you do talk rubbish.
Well put. The eventual value will likely to be comparable to those already ‘test ready’. Only hold back is non USAsife exposure , however Cytiva will put that in hand no doubt.
Patience is a virtue...
GLA
Not sure I agree. Opening economies and societies won’t be influenced by 1% here or there.
Of course, they need to be incredibly accurate, but single digit differences is quite trivial given the context.
Look at the chart -this will finish Blue
Ophidian
We're at the mercy of the MM's, they'll rinse and repeat until news lands, the worry is the news better be good as AVCT is not Sona so can't compare with them.
Global - It can drop to £1.20 if it wants. It’s elastic and changing all the time.
Those who got in very early need to stomach the wait, angst and deramping nonsense.
What I will say is, we have seen with both Sona and Sorrento that the share price will rocket like never before once good news comes. Sorrento tagging $14 in after hours trades last night.
I appreciate everyone has an agenda but there is little ambiguity that the company has the potential to be a decent earner for those of us who can see beyond the smoke and mirrors.
What really excites me is we have our infrastructure set up concurrently with LFT optimisation.
Whilst we might not be first past the post, it will come down to who can produce AND supply these en masse.
Say what you like about boohoo, they are masters in proficiency and repeatability re product manufacturing and distribution.
Sorry @Muck165 - crystal ball not behaving. I doubt capacity will be an issue however.
Ophidian
Great post Ophidian - thank you.
Do you have a view on when we might discover who our manufacturing partners are, and what capacity they might have? Thx
We'll be heading towards £1.20 soon if everyday is a 5% drop day
Tree shake price is falling
Will our quicker test also have an impact in the fight against 'stupid'?
https://www.independent.co.uk/news/uk/home-news/coronavirus-sunderland-pub-crawl-test-covid-silksworth-a9654561.html
Ignore Al’s comments and follow Ophidian’s timeline probably more sensible. I am going try and do that from now on. Stage 9 should be by mid August I would hope there will be a RNS once the sensitivities are confirmed.
@CautiousOptimist - yes sorry about the lack of clarity there. I did post an addendum last night (reproduced below) to try and clarify:
for clarity in number 7 it is the . Additional batches made again at pilot scale to clinical standards for first time clinical evaluation that is DONE- the evaluation as we know is ongoing (in part through CONDOR/Falcon)
I think it is already in progress and see no reason why an RNS is required - the News was inclusion to CONDOR not the commencement of testing that was the reason for the BAMS RNS and we already know from that the LFD is in too.
Sit tight not long to go I'm sure
Ophidian
Ophidian, thanks as ever for the insightful update. Do you think we will hear via RNS when they start clinical trials, the same way we did with the BAMS test? Asking for clarity, as I’m not clear whether you include undertaking clinical trials under one of the steps marked DONE, or under the upcoming/ongoing “evaluate data from clinical programme”. Cheers.
So do we go by the ceo statements or do we go by ophidian's impressive timeline, see the problem here.
There is a wide difference in communications pre and post placing.
Many thanks @ophidian appreciate your input & expertise - end August seems a viable target date to get commercial number on sales/order £ revenues confirmed thereby verify improvement in company fundamentals should hopefully trigger company valuation re-rate . Exciting times !
Thanks for the pointers Ophidian.
On page 10, spanning both the Desired and Acceptable columns: “Evidence that live virus is deactivated early in the process.“
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/895745/TPP_Point_of_Care_SARS-CoV-2_Detection_Tests.pdf
@ophidian
Don't worry pal I've seen that Youtube video @doggy found
Jesus wept a thousand tears, how have Sorrento SP gone up that much based on that crock of shiiiiiiiiiiiite
@ophidian
Appreciate the knowledge you put out on the board, I'm certainly learning some valuable info.
I have my own opinion on comparing Sorrento Therapeutics saliva ('spit' as the media have termed it) product but wondered what yours was and where they are in the timeline compared to where avacta sits. They still have to get emergency approval and cost wise look hefty but not sure on other bits. If you have time would like to read what you have to say.
WillHawk
Brilliant stuff Ophidian, thanks a lot and keep it coming.
@RedReversion - I think there is enough evidence if you look for it. This was discussed from sunday evening onwards. The MHRA updated TPP, comments from members of the CONDOR team, publications which include Porton Down personnel as authors for starters. DYOR.
Ophidian
Many thanks for this excellent contribution Ophidian.
Could you possibly elaborate on what makes you think the ‘Optimise LFD for viral inactivation’ step has taken place? Is there any hard evidence for it?
Just a thanks Ophidian - awesome work, keeps the faithful faithful.
Whoever it is that keeps swiping my posts and putting them up on your telegram group - you're welcome. I have my sources.
Ophidian
A tantalising Timeline Ophidian, ta very much. You can run my Titanium mine anytime.